Veterinary Medicines

BOVALTO PASTOBOV

Not authorised
  • Mannheimia haemolytica, serotype A1, strain NL 1009, leucotoxoid
Download as PDF

Product identification

Medicine name:
PASTOBOV
BOVALTO PASTOBOV
Active substance:
  • Mannheimia haemolytica, serotype A1, strain NL 1009, leucotoxoid
Target species:
  • Cattle
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Mannheimia haemolytica, serotype A1, strain NL 1009, leucotoxoid
    68.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • All relevant tissues
        0
        day
  • Subcutaneous use
    • Cattle
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB04
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Ireland
Package description:
  • Box of 10 glass bottles of 1 dose
  • Box of 50 glass bottles of 1 dose
  • Box of 100 glass bottles of 1 dose
  • Box of 5 dose-glass bottle.
  • Box of 10 glass bottles of 5 doses
  • Box of 10 dose-glass bottle
  • Box of 10 glass bottles of 10 doses
  • Box of 1 dose-glass bottle

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10454/028/001
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0101/001